Compare Stocks

→ Bitcoin Rockets To Record High But Buy THIS Instead (From Paradigm Press) (Ad)

Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS).

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
DFFN Diffusion Pharmaceuticals		$4.64	$2.76 ▼ $7.40	$8.98M	1.78	10,937 shs	351,000 shs
GHSI Guardion Health Sciences	$8.04 -0.1%	$8.42	$5.01 ▼ $10.75	$10.29M	0.88	182,041 shs	4,292 shs
ICOTF iCo Therapeutics	$0.39	$0.37	$0.80 ▼ $1.82	$3.53M	2.03	4,760 shs	1,000 shs
REXN Rexahn Pharmaceuticals		$2.06	$1.26 ▼ $4.26	$8.11M	0.98	162,968 shs	2,579 shs
TRPX Therapix Biosciences	$0.10	$0.23	$0.25 ▼ $4.69	$351K	N/A	1.59 million shs	95,212 shs

The Next 7 Blockbuster Stocks for Growth Investors

Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.

Get This Free Report

Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
DFFN Diffusion Pharmaceuticals	0.00%	0.00%	0.00%	0.00%	-37.59%
GHSI Guardion Health Sciences	+0.25%	-0.62%	-10.56%	+54.21%	+29.53%
ICOTF iCo Therapeutics	+5.43%	-4.85%	-12.38%	+6.03%	-2.48%
REXN Rexahn Pharmaceuticals	0.00%	0.00%	0.00%	0.00%	0.00%
TRPX Therapix Biosciences	0.00%	0.00%	0.00%	0.00%	0.00%

Bitcoin Rockets To Record High But Buy THIS Instead (Ad)

Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…

>>Click here to find out what it is.

MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
DFFN Diffusion Pharmaceuticals	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
GHSI Guardion Health Sciences	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
ICOTF iCo Therapeutics	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
REXN Rexahn Pharmaceuticals	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
TRPX Therapix Biosciences	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Analyst Ratings

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
DFFN Diffusion Pharmaceuticals	N/A	N/A	N/A	N/A
GHSI Guardion Health Sciences	2.00	Hold	N/A	N/A
ICOTF iCo Therapeutics	N/A	N/A	N/A	N/A
REXN Rexahn Pharmaceuticals	N/A	N/A	N/A	N/A
TRPX Therapix Biosciences	N/A	N/A	N/A	N/A

Current Analyst Ratings

Latest DFFN, TRPX, REXN, GHSI, and ICOTF Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target	Details
2/2/2024	GHSI Guardion Health Sciences	Maxim Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Hold

(Data available from 4/19/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
DFFN Diffusion Pharmaceuticals	N/A	N/A	N/A	N/A	$6.97 per share	N/A
GHSI Guardion Health Sciences	$12.25M	0.84	$0.14 per share	58.01	$6.39 per share	1.26
ICOTF iCo Therapeutics	N/A	N/A	N/A	N/A	($0.07) per share	N/A
REXN Rexahn Pharmaceuticals	N/A	N/A	N/A	N/A	$2.48 per share	N/A
TRPX Therapix Biosciences	N/A	N/A	N/A	N/A	N/A	N/A

Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
DFFN Diffusion Pharmaceuticals	-$15.59M	N/A	0.00	N/A	N/A	N/A	-69.96%	-62.98%	N/A
GHSI Guardion Health Sciences	$160K	$0.11	73.10	∞	N/A	0.51%	2.01%	1.21%	5/20/2024 (Estimated)
ICOTF iCo Therapeutics	-$1.11M	-$0.40	N/A	∞	N/A	N/A	N/A	-288.85%	N/A
REXN Rexahn Pharmaceuticals	-$8.64M	N/A	0.00	N/A	N/A	N/A	-72.60%	-55.68%	N/A
TRPX Therapix Biosciences	-$4.79M	N/A	0.00	∞	N/A	N/A	N/A	N/A	N/A

Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
DFFN Diffusion Pharmaceuticals	N/A	N/A	N/A	N/A	N/A
GHSI Guardion Health Sciences	N/A	N/A	N/A	N/A	N/A
ICOTF iCo Therapeutics	N/A	N/A	N/A	N/A	N/A
REXN Rexahn Pharmaceuticals	N/A	N/A	N/A	N/A	N/A
TRPX Therapix Biosciences	N/A	N/A	N/A	N/A	N/A

Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
DFFN Diffusion Pharmaceuticals	N/A	10.71	10.71
GHSI Guardion Health Sciences	N/A	9.01	6.98
ICOTF iCo Therapeutics	N/A	0.72	0.72
REXN Rexahn Pharmaceuticals	N/A	3.37	3.37
TRPX Therapix Biosciences	N/A	N/A	N/A

Ownership

Institutional Ownership

Company	Institutional Ownership
DFFN Diffusion Pharmaceuticals	9.95%
GHSI Guardion Health Sciences	20.21%
ICOTF iCo Therapeutics	N/A
REXN Rexahn Pharmaceuticals	7.49%
TRPX Therapix Biosciences	14.32%

Insider Ownership

Company	Insider Ownership
DFFN Diffusion Pharmaceuticals	1.80%
GHSI Guardion Health Sciences	1.32%
ICOTF iCo Therapeutics	N/A
REXN Rexahn Pharmaceuticals	1.10%
TRPX Therapix Biosciences	N/A

Miscellaneous

Company	Employees	Shares Outstanding	Free Float	Optionable
DFFN Diffusion Pharmaceuticals	13	2.04 million	2.00 million	Not Optionable
GHSI Guardion Health Sciences	9	1.28 million	1.27 million	Not Optionable
ICOTF iCo Therapeutics	N/A	9.05 million	N/A	Not Optionable
REXN Rexahn Pharmaceuticals	5	4.48 million	N/A	Optionable
TRPX Therapix Biosciences	9	3.51 million	N/A	Not Optionable

DFFN, TRPX, REXN, GHSI, and ICOTF Headlines

Source	Headline
	Anixa Biosciences Stock (NASDAQ:ANIX), Analyst Ratings, Price Targets, Predictions benzinga.com - December 12 at 5:48 AM
	Sagimet Biosciences Inc (SGMT) investing.com - August 23 at 7:29 AM
	PBIO Pressure BioSciences, Inc. seekingalpha.com - August 1 at 3:24 PM
	Cannabis, Coats, and Social Media: The Good, Bad, and Ugly of 2017's IPOs thestreet.com - January 19 at 7:59 PM

Media Sentiment Over Time

Company Descriptions

Diffusion Pharmaceuticals

NASDAQ:DFFN

Diffusion Pharmaceuticals Inc., a biopharmaceutical company, develops novel therapies that enhance the body's ability to deliver oxygen. Its lead product candidate is Trans Sodium Crocetinate that is developed to enhance the diffusion of oxygen to tissues, as well as to treat COVID-19 disease. The company was founded in 2001 and is based in Charlottesville, Virginia.

Guardion Health Sciences

NASDAQ:GHSI

Guardion Health Sciences, Inc., a clinical nutrition company, develops and distributes clinically supported nutrition, medical foods, and dietary supplements in North America and Europe, and Internationally. The company offers Lumega-Z, a medical food that replenishes and restores the macular protective pigment; and GlaucoCetin, a vision-specific medical food to support and protect the mitochondrial function of optic nerve cells, as well as improve blood flow in the ophthalmic artery in patients with glaucoma. It develops ImmuneSF, a nutraceutical formulation, as well as a portfolio of nutraceutical products under the NutriGuard brand. Further, it distributes medical foods products through e-commerce in an online store, guardionhealth.com. Guardion Health Sciences, Inc. was founded in 2009 and is headquartered in Houston, California.

iCo Therapeutics

OTCMKTS:ICOTF

Satellos Bioscience, Inc. is a regenerative medicine company, which engages in developing novel therapeutics. It operates through a proprietary technology platform, MyoReGenX™ and Leveraging MyoReGenX™, which identify stem cell based regeneration deficits in muscle diseases and develop therapeutic solutions. The company was founded by Frank Gleeson and Michael Rudnicki in 2018 and is headquartered in Toronto, Canada.

Rexahn Pharmaceuticals

NASDAQ:REXN

Ocuphire Pharma, Inc. engages in the research and development of ophthalmic biopharmaceutical products. It focuses on developing and commercializing therapies for the treatment of several eye disorders. The company was founded by Mina Patel Soouch and Alan R. Meyer in February 2018 and is headquartered in Farmington Hills, MI.

Therapix Biosciences

NASDAQ:TRPX

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial